{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T09:51:18Z","timestamp":1756893078436,"version":"3.38.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172037"],"award-info":[{"award-number":["82172037"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515010499"],"award-info":[{"award-number":["2023A1515010499"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiol med"],"DOI":"10.1007\/s11547-024-01907-7","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T13:01:56Z","timestamp":1731416516000},"page":"25-36","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Metastasis-directed ablation of hepatocellular carcinoma with pulmonary oligometastases: a long-term multicenter study"],"prefix":"10.1007","volume":"130","author":[{"given":"Qunfang","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruixia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songsong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kangshun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhimei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,12]]},"reference":[{"key":"1907_CR1","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1007\/s00268-016-3580-4","volume":"40","author":"Y Takahashi","year":"2016","unstructured":"Takahashi Y, Ikeda N, Nakajima J, Sawabata N, Chida M, Horio H et al (2016) Prognostic analysis of surgical resection for pulmonary metastasis from hepatocellular carcinoma. World J Surg 40:2178\u20132185. https:\/\/doi.org\/10.1007\/s00268-016-3580-4","journal-title":"World J Surg"},{"key":"1907_CR2","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/liv.15051","volume":"42","author":"HY Woo","year":"2022","unstructured":"Woo HY, Rhee H, Yoo JE, Kim SH, Choi GH, Kim DY et al (2022) Lung and lymph node metastases from hepatocellular carcinoma: comparison of pathological aspects. Liver Int 42:199\u2013209. https:\/\/doi.org\/10.1111\/liv.15051","journal-title":"Liver Int"},{"key":"1907_CR3","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41392-020-00264-x","volume":"5","author":"A Huang","year":"2020","unstructured":"Huang A, Yang XR, Chung WY, Dennison AR, Zhou J (2020) Targeted therapy for hepatocellular carcinoma. Signal Transduct Target Ther 5:146. https:\/\/doi.org\/10.1038\/s41392-020-00264-x","journal-title":"Signal Transduct Target Ther"},{"key":"1907_CR4","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1097\/jto.0000000000000317","volume":"9","author":"DB Shultz","year":"2014","unstructured":"Shultz DB, Filippi AR, Thariat J, Mornex F, Loo BW Jr, Ricardi U (2014) Stereotactic ablative radiotherapy for pulmonary oligometastases and oligometastatic lung cancer. J Thorac Oncol 9:1426\u20131433. https:\/\/doi.org\/10.1097\/jto.0000000000000317","journal-title":"J Thorac Oncol"},{"key":"1907_CR5","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1053\/j.gastro.2021.12.276","volume":"162","author":"GL Su","year":"2022","unstructured":"Su GL, Altayar O, O\u2019Shea R, Shah R, Estfan B, Wenzell C et al (2022) AGA clinical practice guideline on systemic therapy for hepatocellular carcinoma. Gastroenterology 162:920\u2013934. https:\/\/doi.org\/10.1053\/j.gastro.2021.12.276","journal-title":"Gastroenterology"},{"key":"1907_CR6","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","volume":"382","author":"RS Finn","year":"2020","unstructured":"Finn RS, Qin S, Ikeda M, Galle PR, Ducreux M, Kim TY et al (2020) Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. N Engl J Med 382:1894\u20131905. https:\/\/doi.org\/10.1056\/NEJMoa1915745","journal-title":"N Engl J Med"},{"key":"1907_CR7","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.cell.2018.03.057","volume":"173","author":"S Turajlic","year":"2018","unstructured":"Turajlic S, Xu H, Litchfield K, Rowan A, Chambers T, Lopez JI et al (2018) Tracking cancer evolution reveals constrained routes to metastases: TRACERx renal. Cell 173:581-594.e512. https:\/\/doi.org\/10.1016\/j.cell.2018.03.057","journal-title":"Cell"},{"key":"1907_CR8","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature22364","volume":"545","author":"C Abbosh","year":"2017","unstructured":"Abbosh C, Birkbak NJ, Wilson GA, Jamal-Hanjani M, Constantin T, Salari R et al (2017) Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution. Nature 545:446\u2013451. https:\/\/doi.org\/10.1038\/nature22364","journal-title":"Nature"},{"key":"1907_CR9","doi-asserted-by":"publisher","first-page":"4918","DOI":"10.1172\/jci70354","volume":"123","author":"MC Haffner","year":"2013","unstructured":"Haffner MC, Mosbruger T, Esopi DM, Fedor H, Heaphy CM, Walker DA et al (2013) Tracking the clonal origin of lethal prostate cancer. J Clin Investig 123:4918\u20134922. https:\/\/doi.org\/10.1172\/jci70354","journal-title":"J Clin Investig"},{"key":"1907_CR10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1126\/science.aaf2784","volume":"352","author":"S Turajlic","year":"2016","unstructured":"Turajlic S, Swanton C (2016) Metastasis as an evolutionary process. Science 352:169\u2013175. https:\/\/doi.org\/10.1126\/science.aaf2784","journal-title":"Science"},{"key":"1907_CR11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.5761\/atcs.ra.13-00343","volume":"20","author":"Y Baba","year":"2014","unstructured":"Baba Y, Watanabe M, Yoshida N, Kawanaka K, Yamashita Y, Baba H (2014) Radiofrequency ablation for pulmonary metastases from gastrointestinal cancers. Ann Thorac Cardiovasc Surg 20:99\u2013105. https:\/\/doi.org\/10.5761\/atcs.ra.13-00343","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"1907_CR12","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1200\/JCO.19.00201","volume":"37","author":"DR Gomez","year":"2019","unstructured":"Gomez DR, Tang C, Zhang J, Blumenschein GR, Hernandez M, Lee JJ et al (2019) Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer: long-term results of a multi-institutional, phase II, randomized study. J Clin Oncol 37:1558\u20131565","journal-title":"J Clin Oncol"},{"key":"1907_CR13","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1080\/02656736.2019.1663279","volume":"36","author":"N Lyu","year":"2019","unstructured":"Lyu N, Kong Y, Pan T, Mu L, Sun X, Li S et al (2019) Survival benefits of computed tomography-guided thermal ablation for adrenal metastases from hepatocellular carcinoma. Int J Hyperthermia 36:1003\u20131011. https:\/\/doi.org\/10.1080\/02656736.2019.1663279","journal-title":"Int J Hyperthermia"},{"key":"1907_CR14","doi-asserted-by":"publisher","DOI":"10.12659\/aot.930383","volume":"26","author":"YH Jeong","year":"2021","unstructured":"Jeong YH, Hwang S, Lee GD, Choi SH, Kim HR, Kim YH et al (2021) Surgical outcome of pulmonary metastasectomy for hepatocellular carcinoma recurrence in liver transplant patients. Ann Transpl 26:e930383. https:\/\/doi.org\/10.12659\/aot.930383","journal-title":"Ann Transpl"},{"key":"1907_CR15","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/j.athoracsur.2019.06.086","volume":"108","author":"L Wang","year":"2019","unstructured":"Wang L, Ye G, Zhan C, Sun F, Lin Z, Jiang W et al (2019) Clinical factors predictive of a better prognosis of pulmonary metastasectomy for hepatocellular carcinoma. Ann Thorac Surg 108:1685\u20131691. https:\/\/doi.org\/10.1016\/j.athoracsur.2019.06.086","journal-title":"Ann Thorac Surg"},{"key":"1907_CR16","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1016\/j.jtcvs.2018.12.075","volume":"157","author":"K Shimizu","year":"2019","unstructured":"Shimizu K, Ohtaki Y, Okumura T, Boku N, Horio H, Takenoyama M et al (2019) Outcomes and prognostic factors after pulmonary metastasectomy in patients with colorectal cancer with previously resected hepatic metastases. J Thorac Cardiovasc Surg 157:2049-2057.e2041. https:\/\/doi.org\/10.1016\/j.jtcvs.2018.12.075","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1907_CR17","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jhep.2024.03.003","volume":"81","author":"SH Choi","year":"2024","unstructured":"Choi SH, Lee BM, Kim J, Kim DY, Seong J (2024) Efficacy of stereotactic ablative radiotherapy in patients with oligometastatic hepatocellular carcinoma: a phase II study. J Hepatol 81:84\u201392. https:\/\/doi.org\/10.1016\/j.jhep.2024.03.003","journal-title":"J Hepatol"},{"key":"1907_CR18","doi-asserted-by":"publisher","first-page":"S192","DOI":"10.1016\/j.jvir.2010.04.007","volume":"21","author":"MG Lubner","year":"2010","unstructured":"Lubner MG, Brace CL, Hinshaw JL, Lee FT Jr (2010) Microwave tumor ablation: mechanism of action, clinical results, and devices. J Vasc Interv Radiol 21:S192-203. https:\/\/doi.org\/10.1016\/j.jvir.2010.04.007","journal-title":"J Vasc Interv Radiol"},{"key":"1907_CR19","doi-asserted-by":"publisher","first-page":"2842","DOI":"10.21037\/tlcr-20-1075","volume":"10","author":"K Rangamuwa","year":"2021","unstructured":"Rangamuwa K, Leong T, Weeden C, Asselin-Labat ML, Bozinovski S, Christie M et al (2021) Thermal ablation in non-small cell lung cancer: a review of treatment modalities and the evidence for combination with immune checkpoint inhibitors. Transl Lung Cancer Res 10:2842\u20132857. https:\/\/doi.org\/10.21037\/tlcr-20-1075","journal-title":"Transl Lung Cancer Res"},{"key":"1907_CR20","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1093\/annonc\/mdv037","volume":"26","author":"T de Ba\u00e8re","year":"2015","unstructured":"de Ba\u00e8re T, Aup\u00e9rin A, Deschamps F, Chevallier P, Gaubert Y, Boige V et al (2015) Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases. Ann Oncol 26:987\u2013991. https:\/\/doi.org\/10.1093\/annonc\/mdv037","journal-title":"Ann Oncol"},{"key":"1907_CR21","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41416-021-01404-y","volume":"125","author":"Y Ni","year":"2021","unstructured":"Ni Y, Peng J, Yang X, Wei Z, Zhai B, Chi J et al (2021) Multicentre study of microwave ablation for pulmonary oligorecurrence after radical resection of non-small-cell lung cancer. Br J Cancer 125:672\u2013678. https:\/\/doi.org\/10.1038\/s41416-021-01404-y","journal-title":"Br J Cancer"},{"key":"1907_CR22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2147\/jhc.S290197","volume":"8","author":"K Kim","year":"2021","unstructured":"Kim K, Kim TH, Kim TH, Seong J (2021) Efficacy of local therapy for oligometastatic hepatocellular carcinoma: a propensity score matched analysis. J Hepatocell Carcinoma 8:35\u201344. https:\/\/doi.org\/10.2147\/jhc.S290197","journal-title":"J Hepatocell Carcinoma"},{"key":"1907_CR23","doi-asserted-by":"publisher","first-page":"721","DOI":"10.3109\/02656736.2012.736669","volume":"28","author":"X Li","year":"2012","unstructured":"Li X, Wang J, Li W, Huang Z, Fan W, Chen Y et al (2012) Percutaneous CT-guided radiofrequency ablation for unresectable hepatocellular carcinoma pulmonary metastases. Int J Hyperthermia 28:721\u2013728. https:\/\/doi.org\/10.3109\/02656736.2012.736669","journal-title":"Int J Hyperthermia"},{"key":"1907_CR24","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/hep.29086","volume":"67","author":"JK Heimbach","year":"2018","unstructured":"Heimbach JK, Kulik LM, Finn RS, Sirlin CB, Abecassis MM, Roberts LR et al (2018) AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology 67:358\u2013380. https:\/\/doi.org\/10.1002\/hep.29086","journal-title":"Hepatology"},{"key":"1907_CR25","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.jhep.2019.09.026","volume":"72","author":"JM Llovet","year":"2020","unstructured":"Llovet JM, Lencioni R (2020) mRECIST for HCC: performance and novel refinements. J Hepatol 72:288\u2013306. https:\/\/doi.org\/10.1016\/j.jhep.2019.09.026","journal-title":"J Hepatol"},{"key":"1907_CR26","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ejca.2016.03.081","volume":"62","author":"LH Schwartz","year":"2016","unstructured":"Schwartz LH, Liti\u00e8re S, de Vries E, Ford R, Gwyther S, Mandrekar S et al (2016) RECIST 1.1-Update and clarification: from the RECIST committee. Eur J Cancer 62:132\u2013137. https:\/\/doi.org\/10.1016\/j.ejca.2016.03.081","journal-title":"Eur J Cancer"},{"key":"1907_CR27","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1159\/000523997","volume":"11","author":"J Sun","year":"2022","unstructured":"Sun J, Guo R, Bi X, Wu M, Tang Z, Lau WY et al (2022) Guidelines for diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus in China (2021 Edition). Liver Cancer 11:315\u2013328. https:\/\/doi.org\/10.1159\/000523997","journal-title":"Liver Cancer"},{"key":"1907_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2021.100347","volume":"3","author":"CO Demirtas","year":"2021","unstructured":"Demirtas CO, D\u2019Alessio A, Rimassa L, Sharma R, Pinato DJ (2021) ALBI grade: evidence for an improved model for liver functional estimation in patients with hepatocellular carcinoma. JHEP Rep 3:100347. https:\/\/doi.org\/10.1016\/j.jhepr.2021.100347","journal-title":"JHEP Rep"},{"key":"1907_CR29","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00535-022-01855-x","volume":"57","author":"XH Wang","year":"2022","unstructured":"Wang XH, Hu ZL, Fu YZ, Hou JY, Li WX, Zhang YJ et al (2022) Tenofovir vs. entecavir on prognosis of hepatitis B virus-related hepatocellular carcinoma after curative resection. J Gastroenterol 57:185\u2013198. https:\/\/doi.org\/10.1007\/s00535-022-01855-x","journal-title":"J Gastroenterol"},{"key":"1907_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102065","volume":"61","author":"TY Lee","year":"2023","unstructured":"Lee TY, Hsu YC, Ho HJ, Lin JT, Chen YJ, Wu CY (2023) Daily aspirin associated with a reduced risk of hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: a population-based cohort study. EClinicalMedicine 61:102065. https:\/\/doi.org\/10.1016\/j.eclinm.2023.102065","journal-title":"EClinicalMedicine"},{"key":"1907_CR31","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2023.2677","author":"S Cappuyns","year":"2023","unstructured":"Cappuyns S, Corbett V, Yarchoan M, Finn RS, Llovet JM (2023) Critical appraisal of guideline recommendations on systemic therapies for advanced hepatocellular carcinoma: a review. JAMA Oncol. https:\/\/doi.org\/10.1001\/jamaoncol.2023.2677","journal-title":"JAMA Oncol"},{"key":"1907_CR32","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1200\/jco.20.00808","volume":"38","author":"RS Finn","year":"2020","unstructured":"Finn RS, Ikeda M, Zhu AX, Sung MW, Baron AD, Kudo M et al (2020) Phase Ib study of lenvatinib plus pembrolizumab in patients with unresectable hepatocellular carcinoma. J Clin Oncol 38:2960\u20132970. https:\/\/doi.org\/10.1200\/jco.20.00808","journal-title":"J Clin Oncol"},{"key":"1907_CR33","doi-asserted-by":"publisher","first-page":"5848","DOI":"10.3390\/cancers14235848","volume":"14","author":"TH Kim","year":"2022","unstructured":"Kim TH, Nam TK, Yoon SM, Kim TH, Choi YM, Seong J (2022) Stereotactic ablative radiotherapy for oligometastatic hepatocellular carcinoma: a multi-institutional retrospective study (KROG 20-04). Cancers (Basel) 14:5848. https:\/\/doi.org\/10.3390\/cancers14235848","journal-title":"Cancers (Basel)"},{"key":"1907_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.acr.2020.10.001","volume":"149","author":"S Chidambaranathan-Reghupaty","year":"2021","unstructured":"Chidambaranathan-Reghupaty S, Fisher PB, Sarkar D (2021) Hepatocellular carcinoma (HCC): epidemiology, etiology and molecular classification. Adv Cancer Res 149:1\u201361. https:\/\/doi.org\/10.1016\/bs.acr.2020.10.001","journal-title":"Adv Cancer Res"},{"key":"1907_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(23)00961-3","author":"S Qin","year":"2023","unstructured":"Qin S, Chan SL, Gu S, Bai Y, Ren Z, Lin X et al (2023) Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study. Lancet. https:\/\/doi.org\/10.1016\/s0140-6736(23)00961-3","journal-title":"Lancet"},{"key":"1907_CR36","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/s1470-2045(21)00252-7","volume":"22","author":"Z Ren","year":"2021","unstructured":"Ren Z, Xu J, Bai Y, Xu A, Cang S, Du C et al (2021) Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2\u20133 study. Lancet Oncol 22:977\u2013990. https:\/\/doi.org\/10.1016\/s1470-2045(21)00252-7","journal-title":"Lancet Oncol"},{"key":"1907_CR37","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1158\/2326-6066.cir-21-0515","volume":"10","author":"N Budimir","year":"2022","unstructured":"Budimir N, Thomas GD, Dolina JS, Salek-Ardakani S (2022) Reversing T-cell exhaustion in cancer: lessons learned from PD-1\/PD-L1 immune checkpoint blockade. Cancer Immunol Res 10:146\u2013153. https:\/\/doi.org\/10.1158\/2326-6066.cir-21-0515","journal-title":"Cancer Immunol Res"},{"key":"1907_CR38","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jhep.2023.02.032","volume":"79","author":"J Tan","year":"2023","unstructured":"Tan J, Fan W, Liu T, Zhu B, Liu Y, Wang S et al (2023) TREM2(+) macrophages suppress CD8(+) T-cell infiltration after transarterial chemoembolisation in hepatocellular carcinoma. J Hepatol 79:126\u2013140. https:\/\/doi.org\/10.1016\/j.jhep.2023.02.032","journal-title":"J Hepatol"},{"key":"1907_CR39","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1158\/0008-5472.Can-20-2426","volume":"82","author":"Y Adachi","year":"2022","unstructured":"Adachi Y, Kamiyama H, Ichikawa K, Fukushima S, Ozawa Y, Yamaguchi S et al (2022) Inhibition of FGFR reactivates IFN\u03b3 signaling in tumor cells to enhance the combined antitumor activity of lenvatinib with anti-PD-1 antibodies. Cancer Res 82:292\u2013306. https:\/\/doi.org\/10.1158\/0008-5472.Can-20-2426","journal-title":"Cancer Res"},{"key":"1907_CR40","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41392-022-01235-0","volume":"8","author":"HD Zhu","year":"2023","unstructured":"Zhu HD, Li HL, Huang MS, Yang WZ, Yin GW, Zhong BY et al (2023) Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001). Signal Transduct Target Ther 8:58. https:\/\/doi.org\/10.1038\/s41392-022-01235-0","journal-title":"Signal Transduct Target Ther"}],"container-title":["La radiologia medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-024-01907-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11547-024-01907-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-024-01907-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T11:51:26Z","timestamp":1741348286000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11547-024-01907-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,12]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["1907"],"URL":"https:\/\/doi.org\/10.1007\/s11547-024-01907-7","relation":{},"ISSN":["1826-6983"],"issn-type":[{"type":"electronic","value":"1826-6983"}],"subject":[],"published":{"date-parts":[[2024,11,12]]},"assertion":[{"value":"11 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This retrospective study was performed in accordance with the Declaration of Helsinki. The Ethics Committee Board of the seven hospitals approved this retrospective study and waived the requirement for patient consent for this retrospective review.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}]}}